(0)

Our site is optimized for screen resolutions of 1024 x 768 and higher. We’ve detected yours is set below this. For the best experience, please adjust your resolution. To close this message click here

How Can We Help?

Professional Associations

  • American Bar Association
    • Intellectual Property Law Section
    • Science & Technology Section
    • Young Lawyers Division
  • American Intellectual Property Law Association
  • Bar Association of Erie County
  • New York State Bar Association

In The News

Randolph V. Clower Comments on Possible Implications with Myriad Genetics Case  More

Thomas E. Popek and Randolph V. Clower to Present at High-Tech Rochester Growth Leadership Series Seminar  More

View all for this attorney

Press Releases

Randolph V. Clower Served as an Executive Summary Reviewer for 2013 Rochester Regional Business Plan Contest  More

Richard E. Honen and Randolph V. Clower Participate in Cornell University Pre-Seed Workshop  More

Phillips Lytle LLP Attorneys Thomas E. Popek and Randolph V. Clower to Serve on High Tech Rochester Growth Leadership Series Panel  More

View all for this attorney

Speaking Engagements

Counsel, Pre-Seed Workshop, Cornell University’s Center for Life Science Enterprise, April 2013  More

View all for this attorney

Publications

Author, “Impending Myriad Decision Portends Promethean Consequences For Biotech Industry,” The Metropolitan Corporate Counsel, March 2013  More

Author, “Are Human Genes Patentable?” Phillips Lytle Intellectual Property Client Alert, December 2012  More

Author, “The Cost of Conformity: Patent Reform for Small Business Entrepreneurs,” Life Science News, Buffalo Niagara Enterprise Newsletter, November 2012  More

View all for this attorney

Randolph V. Clower, Ph.D., J.D.
Associate, Buffalo
(716) 847-5421
rclower@phillipslytle.com

Dr. Clower focuses his practice in the area of intellectual property where he possesses a breadth of experience concerning worldwide patent procurement, including prosecuting and preparing patent applications in the fields of microbiology, immunology, oncology, cancer therapeutics, molecular/cellular biology, pharmaceuticals, vaccine biology, DNA-RNA and molecular diagnostics, medical devices, small-molecule inhibitors, hydrogel technology, cell/cell-sheet and stem cell technologies, and various other biotechnology/chemical areas.

Dr. Clower also has experience in drafting non-infringement/invalidity opinions, freedom-to-operate assessments, and patentability evaluations for individual inventors, university clients, small biotechnology companies, and FORTUNE® 500 clients.

Prior to joining Phillips Lytle, Dr. Clower was an associate at Foley & Lardner, LLP and LeClairRyan, PC. He also previously assisted the University at Buffalo Office of Science, Technology Transfer and Economic Outreach (STOR) by drafting patentability assessments.

Dr. Clower served as a graduate research fellow during law school, where he was the recipient of the 2009 ABA and BNA Award for Excellence in the study of IP law and the 2008 Harold A. Dautch Memorial Scholarship. Dr. Clower received his doctorate in microbiology and immunology, and was the recipient of the Pre-Doctorate Training Grant Fellowship for microbial pathogenesis during his graduate education. He earned his bachelors degree in recombinant gene technology while also obtaining a minor in chemistry.

EDUCATION

State University of New York at Buffalo School of Law, J.D., cum laude, 2009
State University of New York at Buffalo School of Medicine and Biomedical Sciences, Ph.D., 2006
State University of New York at Fredonia, B.S., summa cum laude, 2001

ADMITTED TO PRACTICE

New York
Wisconsin
U.S. Patent and Trademark Office - Registered Patent Attorney